Literature DB >> 12576738

Immunologic interaction between infiltrating eosinophils and T lymphocytes in murine spontaneous eosinophilic myocarditis.

Masao Hirasawa1, Hirofumi Deguchi, Akira Ukimura, Yasushi Kitaura.   

Abstract

BACKGROUND: Eosinophilic myocarditis often occurs spontaneously in DBA/2 mice. Relationships between infiltrating eosinophils (Eos), T lymphocytes and interleukin-5 (IL-5) in this disorder were investigated microscopically and immunohistochemically.
METHODS: Hearts from male DBA/2 mice were studied from 5 to 10 weeks of age. Anti-CD4 and anti-CD8 antibodies were used. Infiltrating Eos, white blood cells (WBC), and CD4+ and CD8+ T cells were counted. Interactions were assessed with multiple regression and forward stepwise regression tests. Additionally, IL-5 distribution in heart tissue was histologically observed with special reference to immunological findings.
RESULTS: Beginning at 5 weeks, several necrotic foci containing many damaged cardiocytes were seen in the epicardium of the right ventricle. Eos and lymphocytes were numerous within and around the necrotic foci. Eos were occasionally seen adjacent to degenerating cardiocytes. Three quarters of the mice exhibited such Eo-related myocardial damage. CD4+ lymphocytes were often seen infiltrating actively inflamed foci where Eos could also be observed. The lesional CD4+-to-CD8+ ratio (CD4/CD8) was 5.2 +/- 3.3 at 6 weeks, 6.8 +/- 3.7 at 7 weeks, and 1.5 +/- 0.8 at 10 weeks of age. The lesional Eo/WBC ratio was directly proportional to the CD4/CD8 ratio (p < 0.05), and was also significantly related to lesional CD4+ T cell count (p < 0.05). IL-5 was also expressed in Eo-rich areas.
CONCLUSIONS: In this mouse strain with susceptibility to eosinophilic myocarditis, Eo infiltration was related to increased lesional CD4+ cell count. We suspect that CD4+ T cells induce local eosinotaxis, mediated by IL-5, and participate in myocardiocyte injury via Eo induction. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576738     DOI: 10.1159/000068371

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  7 in total

1.  Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy.

Authors:  M Huntgeburth; M Lindner; J W U Fries; U C Hoppe
Journal:  Z Kardiol       Date:  2005-11

2.  Characterization of a mouse model of hypereosinophilia-associated heart disease.

Authors:  Daniel R Prows; Andrea Klingler; William J Gibbons; Shelli M Homan; Nives Zimmermann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-14       Impact factor: 4.733

3.  Quantitative analysis of myocardial inflammation by flow cytometry in murine autoimmune myocarditis: correlation with cardiac function.

Authors:  Marina Afanasyeva; Dimitrios Georgakopoulos; Diego F Belardi; Amrish C Ramsundar; Jobert G Barin; David A Kass; Noel R Rose
Journal:  Am J Pathol       Date:  2004-03       Impact factor: 4.307

4.  Molecular pathology of murine ureteritis causing obstructive uropathy with hydronephrosis.

Authors:  Osamu Ichii; Saori Otsuka; Yuka Namiki; Yoshiharu Hashimoto; Yasuhiro Kon
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

5.  Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.

Authors:  Nicola L Diny; G Christian Baldeviano; Monica V Talor; Jobert G Barin; SuFey Ong; Djahida Bedja; Allison G Hays; Nisha A Gilotra; Isabelle Coppens; Noel R Rose; Daniela Čiháková
Journal:  J Exp Med       Date:  2017-03-16       Impact factor: 14.307

6.  Heart disease in a mutant mouse model of spontaneous eosinophilic myocarditis maps to three loci.

Authors:  Nives Zimmermann; William J Gibbons; Shelli M Homan; Daniel R Prows
Journal:  BMC Genomics       Date:  2019-10-11       Impact factor: 3.969

7.  Inhibition of Bcl2L12 Attenuates Eosinophilia-Related Inflammation in the Heart.

Authors:  Xiao Chen; Mei-Zhen Zhao; Bei-Ping Miao; Zhi-Qiang Liu; Gui Yang; Jiang-Qi Liu; Ping-Chang Yang; Jiang-Ping Song
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.